The 2020 – 2021 award cycle is anticipated to support at least $7.6 million in new funding. Proposals will be accepted for Established Investigator, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Other Special Opportunities include awards focused on Immunotherapy, Radiation Oncology, Pediatric Melanoma, Melanoma Brain Metastasis, and for researchers in the UK and Israel.
MRA encourages applications from a diverse pool of investigators.
All applications are due by 5:00pm Eastern time on November 4, 2020.
URL for more information:
Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP
Filed Under: Funding Opportunities